Clinical Trial Update: Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for a phase II/III study evaluating SPH4336 plus letrozole versus placebo plus letrozole as first-line treatment in locally advanced or me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• SPH4336

Snippet

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Conditions: Locally Advanced or Metastatic Breast Cancer | Phase 2, Phase 3 | Status: RECRUITING